How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Visual Prosthesis Market
- By Product Type: Retinal Implants, Cortical Implants, Optic Nerve Implants, Subretinal Implants
- By Technology: Microelectrode Arrays, Photovoltaic Implants, Wireless Stimulation Systems, Electrode-based Stimulation
- By Indication: Retinitis Pigmentosa, Age-related Macular Degeneration, Glaucoma, Optic Neuropathy
- By End User: Hospitals, Specialty Eye Clinics, Research Institutes, Rehabilitation Centers
- By Implant Location: Epiretinal, Subretinal, Suprachoroidal, Cortical
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Retinal Implants leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.176 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.184 →
Full report · locked preview
Everything inside the Visual Prosthesis Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 4
Technology 4
Indication 4
End User 4
Implant Location 4
Companies profiled
Second Sight Medical Products Inc.
Pixium Vision
Bionic Vision Technologies
Retina Implant AG
Monash Vision Group
Nano Retina Ltd.
IrisVision
Ocumetics Technology Corp.
Nidek Co. Ltd.
Optobionics Inc.
Alpha IMS (Retina Implant AG)
Bionic Vision Technologies Pty Ltd
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Second Sight Medical Products Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Pixium Vision
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bionic Vision Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Retina Implant AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Monash Vision Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Nano Retina Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →IrisVision
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Ocumetics Technology Corp.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nidek Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Optobionics Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Alpha IMS (Retina Implant AG)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Bionic Vision Technologies Pty Ltd
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Cochlear Limited (Visual Prosthesis Division)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →NeuroVision Technology Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →EpiRet Technologies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,853M by 2033 · 10.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Retinal Implants60.0
- Cortical Implants10.8
- Optic Nerve Implants14.2
- Subretinal Implants15.0
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$430.2M → $1,028M · 11.5%
Europe$299.9M → $661.9M · 10.4%
Asia Pacific$273.8M → $669.9M · 11.8%
Latin America$169.5M → $359.1M · 9.8%
Middle East and Africa$130.4M → $266.0M · 9.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.242026
10.252027
10.252028
10.262029
10.292030
10.302031
10.302032
10.312033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Second Sight Medical Products Inc.17.5
- Pixium Vision20.8
- Bionic Vision Technologies10.4
- Retina Implant AG5.3
- Monash Vision Group7.9
- Nano Retina Ltd.10.0
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type21.6%
Technology22.4%
Indication14.2%
End User29.3%
Implant Location12.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.4
- Europe22.2
- Asia Pacific22.4
- Latin America12.0
- Middle East and Africa8.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Second Sight Medical Products Inc. | 75 | 74 | 94 | 79 | 78 | 79 | 80 |
| Pixium Vision | 81 | 72 | 86 | 81 | 72 | 92 | 81 |
| Bionic Vision Technologies | 71 | 62 | 86 | 87 | 70 | 66 | 74 |
| Retina Implant AG | 77 | 67 | 77 | 76 | 73 | 69 | 73 |
| Monash Vision Group | 68 | 69 | 60 | 68 | 64 | 74 | 67 |
| Nano Retina Ltd. | 60 | 59 | 57 | 64 | 60 | 58 | 60 |
| IrisVision | 52 | 44 | 60 | 45 | 65 | 49 | 53 |
| Ocumetics Technology Corp. | 40 | 60 | 37 | 58 | 41 | 39 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Second Sight Medical Products Inc.
- Pixium Vision
- Bionic Vision Technologies
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Second Sight Medical Products Inc. | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Pixium Vision | ✓ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Bionic Vision Technologies | − | ◐ | ✓ | ✓ | ◐ | − |
| Retina Implant AG | ✓ | − | ✓ | ✓ | ◐ | ◐ |
| Monash Vision Group | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Nano Retina Ltd. | − | − | − | ◐ | − | − |
| IrisVision | ◐ | − | ◐ | ◐ | ◐ | − |
| Ocumetics Technology Corp. | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Pixium Vision81
2Second Sight Medical Products Inc.80
3Bionic Vision Technologies74
4Retina Implant AG73
5Monash Vision Group67
6Nano Retina Ltd.60
7IrisVision53
8Ocumetics Technology Corp.46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Second Sight Medical Products Inc.Pixium Vision
Challenger3
Strong scale, closing on the leaders.
Bionic Vision TechnologiesRetina Implant AGMonash Vision Group
Contender1
Focused players with pockets of strength.
Nano Retina Ltd.
Niche2
Specialists in a single segment or region.
IrisVisionOcumetics Technology Corp.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Visual Prosthesis Market — a $606M beachhead inside a $8.07B market.
Beachhead (SOM)$606Mobtainable near-term
Serviceable (SAM)$3.31Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Retinal Implants
Best fit — highest urgency & budget in Product Type.
Economic buyer79 fit
Cortical Implants
Strong fit — clear ROI and a fast path to value.
End user70 fit
Optic Nerve Implants
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Indication
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel29%
Digital / self-serve18%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Visual Prosthesis Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified20%
Evaluation15%
Closed-won6%
$15.1KCAC
$80KLTV
5.3:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Visual Prosthesis Market is a resilient opportunity — $1.45B by 2033, compounding at 3.4%.
TAM · 2025$1.11Btoday
TAM · 2033$1.45Bforecast
CAGR3.4%2027–2033
Cumulative$11.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.45BTotal addressable market
SAM$575MServiceable available market
SOM$115MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.4% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.45BLarge & growingTAM by 2033 at 3.4% CAGR
$575MServiceable nowreachable with today’s model
$115MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.13BBear2.2% CAGR
$1.45BBase3.4% CAGR
$1.85BBull4.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Visual Prosthesis Market — a $1.20B market by 2033. Plan: grow share from 10.1% to 16.6%.
Market size · 2033$1.20Btotal addressable
Market CAGR3.5%2027–2033
Target share16.6%from 10.1% today
Revenue ambition$198Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.1% | 16.6% | Behind |
| Revenue | $122M | $198M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 28.1% | 38.9% | At risk |
| Customer retention | 90.7% | 95.9% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Technology capability
A defensible second engine — invest in Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $21M capacity & capability investment
- Greenlight bolt-on M&A in Technology
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeOn track
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Visual Prosthesis Market conversation — a $9.04B market you can size, segment and defend in minutes.
Market size · 2033$9.04Btotal opportunity
Growth9.9%CAGR to 2033
Addressable buyers933+accounts in scope
Typical ROI7.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.3×return on cost, year one
< 3 mopayback period
$64K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Second Sight Medical Products Inc.Pixium VisionBionic Vision TechnologiesRetina Implant AGMonash Vision GroupNano Retina Ltd.IrisVisionOcumetics Technology Corp.+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Visual Prosthesis Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Visual Prosthesis Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Visual Nurse Call Systems Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportVisually Impaired Equipments Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportVisually Impaired Assistance Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportVisual Laryngeal Mask Airway Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportVisual Inspection Machines for Capsules and Tablets Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportVisual Function Detection Integrated Equipment Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportVisual Field Testing Equipment Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportVisual Earpick Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportVisual Dispensing System Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportVisual-Aid Device for the Blind Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportVISTA Antibody Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportVisor Magnifiers Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.